568
Views
113
CrossRef citations to date
0
Altmetric
Review Article

Selenium and selenium-antagonistic elements in nutritional cancer prevention

Pages 10-17 | Accepted 22 Oct 2008, Published online: 01 Mar 2009

References

  • Achanzar WE, Diwan BA, Liu J, Quader ST, Webber, MM, and Waalkes MP. (2001). Cadmium-induced malignant transformation of human prostate epithelial cells. Can. Res. 61: 455–458.
  • Beck MA, Nelson HK, Shi Q, Van Dael P, Schiffrin EJ, Blum S, Barclay D, and Levander OA. 2001. Selenium deficiency increases the pathology of an influenza virus infection. FASEB J. 15: 1481–1483.
  • Brinkman M, Reulen RC, Kellen E, Buntinx F, and Zeegers M. 2006. Are men with low selenium levels at increased risk of prostate cancer? Eur. J. Can. 154: 2335–2342.
  • Charalabopoulos K, Kotsalos A, Batistatou A, Charalabopoulos A, Vezyraki P, Peschos D, Kalfakakou V, and Evangelou A. 2006. Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA. BJC. 95: 674–676.
  • Clark LC, Combs GF Jr, Turnbull BW, Slate E, and Alberts D. 1996. The nutritional prevention of cancer with selenium 1983–1993: a randomized clinical trial. JAMA. 276: 1957–1963.
  • Combs GF, Watts JJ, Johnson LK, Canfield WK, Davis CD, and Milner JA. 2008. Absence of diabetes indicators in a selenium-supplementation trial. J. Fed. Amer. Socs. Expl Biol. 22: Abstract 696.4.
  • Coughlin SS, Neaton JD, and Sengupta A. 1996. Cigarette smoking as a predictor of death from prostate cancer in 348,874 men screened for the multiple risk factor intervention trial. Am. J. Epidemiol. 143: 1002–1006.
  • Cui Y, Vogt S, Olson N, Glass AG, and Rohan TE. 2007. Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer. Can. Epidemiol. Biomark. Prev. 16: 1682–1685.
  • Dorgan JF, Sowell A, Swanson CA, Potischman N, Miller R, Schussler N, and Stephenson HEJr. 1998. Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: results form a prospective study in Columbia, Missouri (US). Can. Caus. Cont. 9: 89–97.
  • Drasch G, Schöpfer J, and Schrauzer GN. 2004. Selenium/cadmium ratios in human prostates. Indicators of prostate cancer risk of smokers and nonsmokers, and relevance to the cancer protective effects of selenium. Biol. Trace El. Res. 102: 1–5.
  • Fahey TJ, and Finley DJ. 2004. Dietary supplement may be future treatment for thyroid cancer. ATA News Release, Oct. 2004.
  • Finley DH. (with Fahey TJ) 2004. Lecture presented on Friday, Oct. 1, 2004, at the 76th Annual Meeting of the American Thyroid Association in Vancouver, British Columbia, Canada.
  • Garcia-Morales P, Saceda M, Kenney N, Kim N, Salomon DS, Gottardis MM, Solomon HB, Sholler PF, Jordan VC, and Martin MB. 1994. Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J. Biol. Chem. 24:16896–16901.
  • Gerhardsson L, Brune D, Nordberg IG, and Wester PO. 1985. Protective effect of selenium on lung cancer in smelter workers. Br. J. Ind. Med. 42: 617–626.
  • Ghadirian P, Maisonneuve P, Perret C, Kennedy G, Boyle P, Krewski D, and Lacroix A. 2000. A case-control study of toenail selenium and cancer of the breast, colon and prostate.
  • Glattre E, Thomassen Y, Thoresen Sø, Haldorsen T, Lund-Larsen PG, Theodorsen L, and Aaseth J. 1988. Prediagnostic serum selenium in a case-control study of thyroid cancer. Internat. J. Epid. 18: 45–49.
  • Gromadzinska J, Reszka E, Bruzelius K, Wasowicz W, and Akesson B. 2008. Selenium and cancer: biomarkers of selenium status and molecular action of selenium supplements. Eur. J. Nutr. 47 Suppl 2: 29–50.
  • Gromadzin’ska J, Wasowicz W, Sklodowska M, Bulikowski W, and Rydzyn’ski K. 1996. The influence of atmospheric chromium on selenium content and glutathione peroxidase activity in blood of tannery workers. Environ. Health Perspect. 104: 1312–1316.
  • Habib FK, Hammond GL, Lee IR, Dawson JB, Mason MK, Smith PH, and Stitch SR. 1976. Metal–androgen interrelationships in carcinoma and hyperplasia of the human prostate. J. Endocrin. 71: 133–141.
  • Hickey K, Do A, and Green A. 2001. Smoking and prostate cancer. Epid. Rev. 23: 215–225.
  • Holland JF, and Pogo BGT. 2004. Mouse tumor virus-like viral infection in human breast cancer. Clin. Can. Res. 10: 5647–5649.
  • Hunter DJ, Morris JS, Stampfer MJ, Colditz GA, Speizer FE, and Willett WC. 1990. A prospective study of selenium status and breast cancer risk. J. Am. Med. Assoc. 264: 1128–1131.
  • Ionescu JG, Novotny J, Stejskal V, Lätsch A, Blaurock-Busch E, Eisenmann-Klein M. 2006. Hohe Akkumulation von übergangsmetallen im Brustkrebsgewebe. Umwelt medizin gesellschaft 19: 269–273.
  • Jackson MI, and Combs GF Jr. 2008. Selenium and anticarcinogenesis: underlying mechanisms. Curr. Opin. Clin. Nutr. Metab. Care 11:718–726.
  • Jamba L, Nehruv B, and Bansalv MP. 1997. Selenium supplementation during cadmium exposure. J. Trace Elem. Expv. Med. 10: 233–242.
  • Kellen E, Zeegers M, and Buntix F. 2006. Selenium is inversely associated with bladder cancer risk. A report from the Belgian case-control study on bladder cancer. Int. J. Urol. 13L: 1180–1184.
  • Koskinen T, Pyykkö K, KudoR, Jokela H, and Punnonen R. 1987. Serum selenium, vitamin A, vitamin E and cholesterol concentrations in Finnish and Japanese postmenopausal women. Internat. J. Vit. Nutr. Res. 57: 111–114.
  • Lemly AD. 1995. Assessing the toxic threat of selenium to fish and aquatic birds. Environ. Monit. Assess. 43: 19–35.
  • Levander OA, and Beck MA. 1997. Insights from coxsackie virus B-induced myocarditis in mice deficient in selenium or vitamin E. Biol. Trace El. Res. 56: 5–21.
  • Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IMJr, Kristal AR, Santella RM, Probstfield JL, Moinpour CM, Albanes D, Taylor PR, Minasian LM, Hoque A, Thomas SM, Crowley JJ, Gaziano JM, Stanford JL, Cook ED, Fleshner NE, Lieber MM, Walther PJ, Khuri FR, Karp DD, Schwartz GG, Ford LG, Coltman CA Jr. 2005. Designing the selenium and vitamin E cancer prevention trial (SELECT). J. Natl Can. Inst. 97: 94–102.
  • McElroy JA, Shafer MM, Trentham-Dietz A, Hampton JM, and Newcomb PA. 2006. Cadmium exposure and human breast cancer risk. J. Natl Can. Inst. 98: 869–873.
  • Männistö S, Alfthan G, Virtanen M, Kataja V, Uusitupa M, and Pietinen P. 2000. Toenail selenium and breast cancer – a case-control study in Finland. Eur. J. Clin. Nutr. 54: 98–103.
  • Medina D, and Shepherd F. 1980. Selenium mediated inhibition of mouse mammary tumorigenesis. Can. Lett. 8: 241–245.
  • Melana SM, Nepomnaschy U, Sakalian M, Abbott A, Hasa J, Holland JF, and Pogo BGT. 2007. Characterization of viral particles isolated from primary cultures of human breast cancer cells. Can. Res. 67: 8960–8965.
  • Meplan C, Mann K, and Hainaut P. 1999. Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured cells. J. Biol. Chem. 274: 31663–31670.
  • Mesa-Tejada R, Kedyar I, Ramanarayanan M, Ohno T, Fenoglio C, and Spiegelman S. 1978. Detection in human breast carcinomas of an antigen immunologically related to a group-specific antigen of mouse mammary tumor virus. Proc. Natl Acad. Sci. USA. 75: 1529–1533.
  • Mondragon MC, and Jaffe WG. 1976. Content of selenium in foods consumed in Venezuela. Arch. Latinoamer. Nutr. 26: 341–352.
  • Morris JS, Rohan T, Soskolne CL, Jain M, Horsman TL, Spate VL, Baskett CK, Mason MM, and Nichols TA. 2001. Selenium status and cancer mortality in subjects residing in four Canadian provinces. J. Radioanal. Nucl. Chem. 249: 421–427.
  • Nelson RL. 1984. Is the changing pattern of colorectal cancer caused by selenium deficiency? Dis. Colon Rectum 27: 459–461.
  • Papp LV, Lu J, Holmgren A, and Khanna KK. 2007. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antiox. Redox. Signal. 9: 775–806.
  • Peters U, Chatterjee N, Church TR, Mayo C, Sturup S, Foster CB, Schatzkin A, and Hayes RB. 2006. Advanced colorectal adenoma in a colorectal cancer early detection program. Can. Epidemiol. Biomark. Prev. 15: 315–320.
  • Peters U, Foster CB, Chatterjee N, Schatzkin A, Reding D, Andriole GL, Crawford ED, Sturup S, Chanoc SJ, and Hayes RB. 2007. Serum selenium and risk of prostate cancer – a nested case-control study. Am. J. Clin. Nutr. 85: 209–217.
  • Plaskon LA, Penson DF, Vaughan TL, and Stanford JL. 2003. Cigarette smoking and risk of prostate cancer in middle-aged men. Can. Epid. Biomark. Prev. 12: 604–609.
  • Rao L, Puschner B, and Prolla TA. 2001. Gene expression profiling of low selenium status in the mouse intestine transcriptional activation of genes linked to DNA damage, cell cycle control and oxidative stress. J. Nutr. 131: 3175–3181.
  • Rayman MP. 2005. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc. Nutr. Soc. 64: 527–542
  • Riley F. 1969. Mast cells. Cocarcinogenesis and anticarcinogenesis in the skin of mice. Experientia (Basel) 24: 1237–1238.
  • Roy M, Kiremidjian-Schumacher L, Wishe HI, Cohen MW, and Stotzky G. 1995. Supplementation with selenium augments the functions of natural killer and lymphokine-activated killer cells. Proc. Soc. Exp. Med. 209: 369–375.
  • Schöpfer J, Drasch G, and Schrauzer GN. 2004. Selenium/cadmium ratios in human prostates. Indicators of prostate cancer risk of smokers and nonsmokers, and relevance to the cancer protective effects of selenium. Biol. Trace El. Res. 102: 1–5.
  • Schrauzer GN. 1992. Mechanistic aspects of anticarcinogenic action. Biol. Trace El. Res. 33: 51–62.
  • Schrauzer GN. 2000. Anticarcinogenic effects of selenium CMLS. Cell. Molec. Life Sci. 57: 1864–1873.
  • Schrauzer GN. 2003. The nutritional significance, metabolism and toxicology of selenomethionine. Adv. Food Nutri. Res. 47:73–112.
  • Schrauzer GN. 2006. Interactive effects of selenium and chromium on mammary tumor development and growth in MMTV-infected female mice and their relevance to human cancer. Biol. Trace El. Res. 109: 281–292.
  • Schrauzer GN. 2008. Interactive effects of selenium and cadmium on mammary tumor development and growth in mmtv-infected female mice. A model study on the roles of cadmium and selenium in human breast cancer. Biol. Trace El. Res. 123: 27–34.
  • Schrauzer GN, and Ishmael D. 1974. Effect of selenium and arsenic on the genesis of spontaneous mammary tumors in inbred female C3H mice. Ann. Clin. Lab. Sci. 4: 441–447.
  • Schrauzer GN, and Rhead WJ. 1971. Interpretation of the methylene blue reduction test of human plasma and the possible cancer-protecting effect of selenium. Experientia 27: 1069–1071.
  • Schrauzer GN, and White DA. 1978. Selenium in human nutrition: dietary intakes and effects of supplementation. Bioinorg. Chem. 8: 303–318.
  • Schrauzer GN, Kuehn K, and Hamm D. 1980a. Effects of dietary selenium and lead on the genesis of spontaneous mammary tumors in mice. Biol. Trace El. Res. 3: 185–196.
  • Schrauzer GN, McGinness JE, and Kuehn K. 1980b. Effects of temporary selenium supplementation on the genesis of mammary tumorigenesis in inbred female C3H/St mice. Carcinogenesis 1: 199–201.
  • Schrauzer GN, Molenaar T, Kuehn K, and Waller D. 1989. Effect of simulated American, Bulgarian, and Japanese human diets and of selenium supplementation on the incidence of virally induced mammary tumors in female mice. Biol. Trace El. Res. 20: 169–178.
  • Schrauzer GN, Molenaar T, Mead S, Kuehn K, Yamamoto H, and Arakio E. 1985. Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease. Jpn J. Can. Res. (Gann) 76: 374–377.
  • Schrauzer GN, Rhead WJ, and Evans JA. 1973. Selenium and cancer, chemical interpretation of a plasma cancer test. Bioinorg. Chem. 2: 329–340.
  • Schrauzer GN, White DA, McGinness JE, Schneider CJ, and Bell LJ. 1978. Arsenic and cancer: effects of the joint administration of arsenic and selenium on the genesis of spontaneous mammary tumors in mice. Bioinorg. Chem. 9: 245–253.
  • Schrauzer GN, White DA, and Schneider CJ. 1976a. Inhibition of the genesis of spontaneous mammary tumors in C3H mice: effects of selenium and selenium antagonistic elements and their possible role in human breast cancer. Bioinorg. Chem. 5: 265–270.
  • Schrauzer GN, White DA, and Schneider CJ. 1976b. Selenium and cancer. Effects of selenium and of the diet on the genesis of spontaneous mammary tumors in virgin inbred C3H/St mice. Bioinorg. Chem. 8: 387–396.
  • Schrauzer GN, White DA, and Schneider CJ. 1977a. Cancer mortality correlation studies – III. Statistical associations with dietary selenium intakes. Bioinorg. Chem. 7: 23–34.
  • Schrauzer GN, White DA, Schneider CJ. 1977b. Cancer mortality correlation studies – IV. Associations with dietary selenium intakes of certain trace elements, notably Se-antagonists. Bioinorg. Chem. 7: 35–56.
  • Schwarz K, and Foltz CM. 1957. Selenium as an integral part of Factor 3 against dietary necrotic liver degeneration. J. Am. Chem. Soc. 79: 3292–3293.
  • Shamberger RJ, and Frost DV. 1969. Possible protective effect of selenium against human cancer. Can. Med. Assoc. J. 100: 682.
  • Shamberger RJ, and Rudolph G. 1966. Protection against cocarcinogenesis by antioxidants Experientia (Basel) 22: 116–122.
  • Shamberger RJ, and Willis CE. 1971. Selenium distribution and human cancer mortality Crit. Rev. Clin. Lab. Sci. 2: 211–221.
  • Shamberger RJ, Rukovena E, Longfield AK, Tytko SA, Deodhar S, and Willis CE. 1973. Antioxidants and cancer. I. Selenium in the blood of normals and cancer patients. J. Natl Can. Inst. 50: 863–870.
  • Siddiqui MK, Jyoti Singh S, Mehrotra PK, Singh K, and Sarangi R. 2006. Comparison of some trace elements concentration in blood, tumor free breast and tumor tissues of women with benign and malignant breast lesions: an Indian study. Environ. Int. 32: 630–637.
  • Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, Cappuccio FP, Ceriello A, and Reid ME. 2007. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomised trial. Ann. Intern. Med. 147: 217–223.
  • Tsugane S, de Souza JMP, Costa ML, Mirra AP, Gottlieb SLD, Laurenti R, and Watanabev S. 1990. Cancer incidence rates among Japanese immigrants in the city of Sao Paulo, Brazil. Can. Causes Cont. 1: 189–193.
  • van den Brandt PA, Goldbohm RA, van’t Veer P, Bode P, Dorant E, Hermus RJJ, and Sturmans F. 1993. A prospective cohort study on selenium status and the risk of lung cancer. Can. Res. 53: 4860–4865.
  • van den Brandt PA, Goldbohm RA, van’t Veer P, Bode P, Dorant E, Hermus RJ, and Sturmans F. 1994. Toenail selenium levels and the risk of breast cancer. Amer. J. Epid. 140: 20–26.
  • van den Brandt PA, Zeegers MPA, Bode P, and Goldbohm RA. 2003. Toenail selenium levels and the subsequent risk of prostate cancer. A prospective cohort study. Can. Epidemiol. Biomark. Prev. 12: 866–871.
  • Van’t Veer P, Strain JJ, Fernandez-Crehuet J, Martin BC, Thamm M, Kardinaal AF, Kohlmeier L, Huttunen JK, Martin-Moreno JM, and Kok FJ. 1996. Tissue antioxidants and postmenopausal breast cancer: The European Community Multicentre Study on Antioxidants, Myocardial Infarction and Cancer of the Breast (EURAMIC). Can. Epid. Biomark. Prev. 5: 441–447.
  • Webber MM. 1985. Selenium prevents the growth stimulating effects of cadmium on human prostatic epithelium. Biochem. Biophys. Res. Comm. 127: 871–877.
  • Weisberg M, Pius J, Hale B, and Beyersmann D. 2003. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 192: 95–117.
  • Yu SY, Zhu YJ, and Li WG. 1997. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol. Trace El. Res. 56: 117–124.
  • Zhu Z, Kimura M, ItokawaY, Aoki T, Takahashi JA, Nakatsu S, Oda Y, and Kikuchi H. 1996. Apoptosis induced by selenium in human glioma cell lines. Biol. Trace El. Res. 54: 123–134.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.